CLOV vs. NU

Last updated Apr 1, 2026

Compare and contrast key facts about Clover Health Investments, Corp. (CLOV) and Nu Holdings Ltd. (NU).

Performance

CLOV vs. NU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and Nu Holdings Ltd. (NU). The values are adjusted to include any dividend payments, if applicable.

CLOV vs. NU - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CLOV Clover Health Investments, Corp.	-25.11%	-25.40%	230.85%	2.43%	-75.01%	-16.40%
NU Nu Holdings Ltd.	-14.16%	61.58%	24.37%	104.67%	-56.61%	-9.20%

Fundamentals

Market Cap CLOV : $910.34M NU : $70.65B
EPS CLOV : -$0.17 NU : $0.58
PS Ratio CLOV : 0.47 NU : 4.58
PB Ratio CLOV : 2.95 NU : 6.26
Total Revenue (TTM) CLOV : $1.92B NU : $15.40B
Gross Profit (TTM) CLOV : $1.99B NU : $6.61B
EBITDA (TTM) CLOV : -$83.86M NU : $3.94B

Returns By Period

In the year-to-date period, CLOV achieves a -25.11% return, which is significantly lower than NU's -14.16% return.

CLOV

• 1D: 2.33%
• 1M: -15.79%
• YTD: -25.11%
• 6M: -42.48%
• 1Y: -50.97%
• 3Y*: 27.70%
• 5Y*: -24.93%
• 10Y*: —

NU

• 1D: 6.37%
• 1M: -4.07%
• YTD: -14.16%
• 6M: -10.24%
• 1Y: 40.33%
• 3Y*: 44.53%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CLOV vs. NU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV

CLOV Risk / Return Rank: 9
CLOV Sharpe Ratio Rank: 10
CLOV Sortino Ratio Rank: 10
CLOV Omega Ratio Rank: 12
CLOV Calmar Ratio Rank: 6
CLOV Martin Ratio Rank: 6

NU

NU Risk / Return Rank: 72
NU Sharpe Ratio Rank: 76
NU Sortino Ratio Rank: 69
NU Omega Ratio Rank: 69
NU Calmar Ratio Rank: 70
NU Martin Ratio Rank: 75

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLOV vs. NU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Nu Holdings Ltd. (NU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CLOV	NU	Difference
Sharpe ratio Return per unit of total volatility	-0.78	1.01	-1.79
Sortino ratio Return per unit of downside risk	-1.06	1.53	-2.58
Omega ratio Gain probability vs. loss probability	0.87	1.20	-0.33
Calmar ratio Return relative to maximum drawdown	-0.93	1.39	-2.32
Martin ratio Return relative to average drawdown	-1.69	4.16	-5.85
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CLOV vs. NU - Sharpe Ratio Comparison

The current CLOV Sharpe Ratio is -0.78, which is lower than the NU Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of CLOV and NU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CLOV	NU	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.78	1.01	-1.79
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.28	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.31	0.14	-0.44

Correlation

The correlation between CLOV and NU is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CLOV vs. NU - Dividend Comparison

Neither CLOV nor NU has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

CLOV vs. NU - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, which is greater than NU's maximum drawdown of -72.07%. Use the drawdown chart below to compare losses from any high point for CLOV and NU.

Drawdown Indicators

	CLOV	NU	Difference
Max Drawdown Largest peak-to-trough decline	-97.19%	-72.07%	-25.12%
Max Drawdown (1Y) Largest decline over 1 year	-54.97%	-27.99%	-26.98%
Max Drawdown (5Y) Largest decline over 5 years	-97.19%	—	—
Current Drawdown Current decline from peak	-92.05%	-23.40%	-68.65%
Average Drawdown Average peak-to-trough decline	-76.30%	-29.90%	-46.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	30.15%	9.34%	+20.81%

Volatility

CLOV vs. NU - Volatility Comparison

The current volatility for Clover Health Investments, Corp. (CLOV) is 11.60%, while Nu Holdings Ltd. (NU) has a volatility of 12.28%. This indicates that CLOV experiences smaller price fluctuations and is considered to be less risky than NU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CLOV	NU	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.60%	12.28%	-0.68%
Volatility (6M) Calculated over the trailing 6-month period	47.49%	27.59%	+19.90%
Volatility (1Y) Calculated over the trailing 1-year period	65.84%	39.99%	+25.85%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	89.37%	59.14%	+30.23%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	86.00%	59.14%	+26.86%

Financials